Literature DB >> 16424207

Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa.

Mette Møller-Kristensen1, W K Eddie Ip, Lei Shi, Lakshmi D Gowda, Michael R Hamblin, Steffen Thiel, Jens Chr Jensenius, R Alan B Ezekowitz, Kazue Takahashi.   

Abstract

Burn injury disrupts the mechanical and biological barrier that the skin presents against infection by symbionts like the Pseudomonas aeruginosa, a Gram-negative bacteria. A combination of local factors, antimicrobial peptides, and resident effector cells form the initial response to mechanical injury of the skin. This activity is followed by an inflammatory response that includes influx of phagocytes and serum factors, such as complement and mannose-binding lectin (MBL), which is a broad-spectrum pattern recognition molecule that plays a key role in innate immunity. A growing consensus from studies in humans and mice suggests that lack of MBL together with other comorbid factors predisposes the host to infection. In this study we examined whether MBL deficiency increases the risk of P. aeruginosa infection in a burned host. We found that both wild-type and MBL null mice were resistant to a 5% total body surface area burn alone or s.c. infection with P. aeruginosa alone. However, when mice were burned then inoculated s.c. with P. aeruginosa at the burn site, all MBL null mice died by 42 h from septicemia, whereas only one-third of wild-type mice succumbed (p = 0.0005). This result indicates that MBL plays a key role in containing and preventing a systemic spread of P. aeruginosa infection following burn injury and suggests that MBL deficiency in humans maybe a premorbid variable in the predisposition to infection in burn victims.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424207      PMCID: PMC3071691          DOI: 10.4049/jimmunol.176.3.1769

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

1.  Pathophysiologic events related to thermal injury of skin.

Authors:  P A Ward; G O Till
Journal:  J Trauma       Date:  1990-12

2.  Differential recognition of core and terminal portions of oligosaccharide ligands by carbohydrate-recognition domains of two mannose-binding proteins.

Authors:  R A Childs; T Feizi; C T Yuen; K Drickamer; M S Quesenberry
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

3.  Distribution and survival of Escherichia coli translocating from the intestine after thermal injury.

Authors:  J W Alexander; L Gianotti; T Pyles; M A Carey; G F Babcock
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

4.  Association of low levels of mannan-binding protein with a common defect of opsonisation.

Authors:  M Super; S Thiel; J Lu; R J Levinsky; M W Turner
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321

5.  Microvascular permeability to macromolecules in thermal injury.

Authors:  G Arturson
Journal:  Acta Physiol Scand Suppl       Date:  1979

6.  Ligand-binding characteristics of rat serum-type mannose-binding protein (MBP-A). Homology of binding site architecture with mammalian and chicken hepatic lectins.

Authors:  R T Lee; Y Ichikawa; M Fay; K Drickamer; M C Shao; Y C Lee
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

7.  Molecular basis of opsonic defect in immunodeficient children.

Authors:  M Sumiya; M Super; P Tabona; R J Levinsky; T Arai; M W Turner; J A Summerfield
Journal:  Lancet       Date:  1991-06-29       Impact factor: 79.321

8.  Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center.

Authors:  A T McManus; A D Mason; W F McManus; B A Pruitt
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

9.  Distinct and overlapping functions of allelic forms of human mannose binding protein.

Authors:  M Super; S D Gillies; S Foley; K Sastry; J E Schweinle; V J Silverman; R A Ezekowitz
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

10.  Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.

Authors:  M Matsushita; T Fujita
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  40 in total

1.  Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin.

Authors:  Wei-Chuan Chang; Kevan L Hartshorn; Mitchell R White; Patience Moyo; Ian C Michelow; Henry Koziel; Bernard T Kinane; Emmett V Schmidt; Teizo Fujita; Kazue Takahashi
Journal:  Biochem Pharmacol       Date:  2010-10-28       Impact factor: 5.858

2.  Investigating the humoral immune response in chronic venous leg ulcer patients colonised with Pseudomonas aeruginosa.

Authors:  Jasper N Jacobsen; Anders S Andersen; Michael K Sonnested; Inga Laursen; Bo Jorgensen; Karen A Krogfelt
Journal:  Int Wound J       Date:  2010-11-19       Impact factor: 3.315

3.  Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells.

Authors:  Melinda M Dean; Robert L Flower; Damon P Eisen; Robyn M Minchinton; Derek N J Hart; Slavica Vuckovic
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

4.  Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis.

Authors:  Katja Dahlke; Christiane D Wrann; Oliver Sommerfeld; Maik Sossdorf; Peter Recknagel; Svea Sachse; Sebastian W Winter; Andreas Klos; Gregory L Stahl; Yuanyuan Xu Ma; Ralf A Claus; Konrad Reinhart; Michael Bauer; Niels C Riedemann
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

5.  Low circulating mannan-binding lectin levels correlate with increased frequency and severity of febrile episodes in myeloma patients who undergo ASCT and do not receive antibiotic prophylaxis.

Authors:  E Eleutherakis-Papaiakovou; M-A Dimopoulos; E Kastritis; D Christoulas; M Roussou; M Migkou; M Gavriatopoulou; D Fotiou; I Panagiotidis; D C Ziogas; N Kanellias; C Papadimitriou; E Terpos
Journal:  Bone Marrow Transplant       Date:  2017-08-14       Impact factor: 5.483

Review 6.  Mannose-binding lectin and the balance between immune protection and complication.

Authors:  Kazue Takahashi
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

7.  Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation.

Authors:  Kazue Takahashi; Wei-Chuan Chang; Minoru Takahashi; Vasile Pavlov; Yumi Ishida; Laura La Bonte; Lei Shi; Teizo Fujita; Gregory L Stahl; Elizabeth M Van Cott
Journal:  Immunobiology       Date:  2010-03-04       Impact factor: 3.144

8.  Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin.

Authors:  Kenneth Ahrend Petersen; Finn Matthiesen; Teit Agger; Leif Kongerslev; Steffen Thiel; Karen Cornelissen; Mads Axelsen
Journal:  J Clin Immunol       Date:  2006-08-09       Impact factor: 8.317

Review 9.  C-type lectin receptors in tuberculosis: what we know.

Authors:  Surabhi Goyal; Tilman E Klassert; Hortense Slevogt
Journal:  Med Microbiol Immunol       Date:  2016-07-28       Impact factor: 3.402

10.  Mannan-binding lectin is a determinant of survival in infective endocarditis.

Authors:  C T Tran; K Kjeldsen; S Haunsø; N Høiby; H K Johansen; M Christiansen
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.